Sciatica is driven by inflammation at the nerve root as much as by compression. Here is how MSC-derived exosomes are thought to act, and an honest read of the 2026 human evidence.
Stem Cell Therapy for Spinal Cord Injury: 4-Year Results From a World-First Trial
The longest-running safety question in regenerative medicine just received its clearest answer yet. On July 21, 2026,...
Autologous vs. Allogeneic Stem Cell Therapy: A 2026 Patient Guide
If you are researching regenerative medicine, you will quickly meet two words that shape almost every treatment...
Stem Cell Therapy for Back Pain: A 2026 Patient Guide to Regenerative Spine Care
Stem cell therapy for back pain, explained for 2026: how MSC injections target degenerated discs, what the DREAM trial and latest reviews show, the honest FDA status, and how to choose a provider.
What Are MSC-Derived Exosomes? A 2026 Guide to Mesenchymal Stem Cell Exosomes
MSC-derived exosomes are cell-free signaling vesicles from mesenchymal stem cells. Learn how they work, why the source matters, and their 2026 FDA status.
Stem Cell Therapy for Aging Frailty: What a 2026 Phase 2b Trial Found
A new 2026 Phase 2b trial published in Cell Stem Cell reports that intravenous bone marrow mesenchymal stem cells improved six-minute walk distance in older adults with aging frailty. Here is what the result shows, how to read it honestly, the FDA status, and what to verify before treatment.
Regenerative Medicine for Arthritis: A 2026 Guide to Exosome and Stem Cell Therapy
How regenerative medicine treats arthritis in 2026: MSC exosome and stem cell therapy for osteoarthritis and rheumatoid arthritis, what the evidence shows, FDA status, and how to choose a provider.
Stem Cell Therapy for Back Pain: A 2026 Patient Guide to Disc, Facet, and SI Joint Repair
How MSC stem cell therapy treats degenerative disc disease, facet arthritis, and SI joint pain. 2026 trial data, candidate selection, quality questions.
Exosomes and Biological Aging: 2026 Research on Senescence, SIRT1, and Tissue Repair
May 2026 research update on MSC-derived exosomes and biological aging: SIRT1 pathway activation, senescence signatures, skin/joint/cardiovascular aging, and what patients should look for in 2026.
May 2026 Regenerative Medicine Update: New Approvals and Phase III Trials Reshape the Field
May 2026 brought Japan’s first iPS cell approval for Parkinson’s, Capricor’s CAP-1002 BLA milestone, and continued Phase III enrollment in ExoFlo’s ARDS trial. Here is what the latest regenerative medicine news means for patients evaluating exosomes, stem cells, and peptide therapies right now.
Stem Cell Therapy for Neuropathy: A 2026 Patient Guide to Cell-Based Nerve Repair
How MSC therapy and MSC-derived exosomes target the underlying biology of peripheral neuropathy: a 2026 patient guide to mechanisms, evidence, and quality.
Cell Therapy Milestone: FDA Decision on First Duchenne Cardiomyopathy Treatment Set for August 2026
The FDA has set an August 22, 2026 PDUFA date for deramiocel, which could become the first cell-derived therapy approved for Duchenne muscular dystrophy cardiomyopathy. Here is what practitioners need to know about this milestone and the latest exosome therapy developments.
Regenerative Medicine for Arthritis: Your Guide to Modern Treatment Options
Explore how regenerative medicine for arthritis offers new hope through exosome therapy, stem cell treatments, and peptide protocols. Learn about modern alternatives to surgery and long-term medication.
Stem Cell Therapy for Sports Injuries: How MSCs Are Changing Recovery
Stem cell therapy for sports injuries is rapidly becoming one of the most sought-after regenerative treatments in...
Stem Cell Therapy for Back Pain: A Regenerative Alternative to Surgery
Discover how stem cell therapy for back pain offers a regenerative alternative to surgery. Learn about MSC-derived treatments for disc degeneration, herniated discs, and chronic spinal conditions.
Stem Cell Therapy vs. Exosome Therapy: Understanding the Key Differences
The field of regenerative medicine has experienced remarkable growth over the past decade, with stem cell therapy and...


















